Reagents and consumables

Ended Awarded Last action

Contract number
75N91019F00101
Awardee
Awarding agency
Obligated
$49,959

Award facts

Opportunity
Contract value 100% obligated
$49,958.72 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00002 -$714
Funding Only Action P00001 · To DE-obligate funds from FY2019 expiring lines in accordance with NIH oalm communication 23-18 -$43
Original award $50,716

About this award

The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on December 4, 2018, with a ceiling value of $49,958.72 for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers.

Place of performance is Castleton, IN 46256. The order was issued on a firm fixed-price basis with an ultimate completion date of January 15, 2019. The delivery order was issued to de-obligate funds from FY2019 expiring lines in accordance with NIH OALM Communication 23-18, with no set-aside applied.

Quick answers

Who was awarded contract 75N91019F00101?

75N91019F00101 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on December 4, 2018.

How much is contract 75N91019F00101 worth?

The government has obligated $49,959 on 75N91019F00101.

Is contract 75N91019F00101 an order under another contract?

Yes. 75N91019F00101 is a delivery order under HHSN261201700010I, an indefinite delivery contract.

Was contract 75N91019F00101 competed?

The extent of competition for 75N91019F00101 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award